➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Johnson and Johnson
Dow
Baxter
Merck

Last Updated: October 27, 2021

DrugPatentWatch Database Preview

Litigation Details for Finjan, Inc. v. Qualys Inc. (N.D. Cal. 2018)


Email this page to a colleague

« Back to Dashboard

Finjan, Inc. v. Qualys Inc. (N.D. Cal. 2018)

Docket ⤷  Try it Free Date Filed 2018-11-29
Court District Court, N.D. California Date Terminated
Cause 35:271 Patent Infringement Assigned To Yvonne Gonzalez Rogers
Jury Demand Both Referred To
Parties FINJAN, INC.; QUALYS INC.
Patents 10,154,990; 10,183,968; 10,183,975; 10,231,964; 10,231,975; 10,231,983; 10,239,954; 10,246,708; 10,266,822; 10,278,974; 10,327,926; 10,331,349; 10,335,388; 10,335,390; 10,335,391; 10,335,397; 10,335,420; 10,335,494; 10,363,320; 10,369,409; 10,370,414; 10,375,964; 10,377,731; 10,379,975; 10,383,344; 10,383,357; 10,383,954; 10,385,399; 10,386,359; 10,386,366; 10,386,376; 10,391,154; 10,392,349; 10,392,357; 10,392,406; 10,392,413; 10,401,371; 10,406,332; 10,406,383; 10,407,393; 10,421,954; 10,494,413; 10,494,414; 10,633,423; 6,183,974; 6,335,369; 6,355,415; 6,355,425; 6,387,383; 6,406,387; 6,406,731; 6,420,322; 6,423,319; 6,613,357; 6,844,390; 6,893,253; 6,893,633; 6,893,639; 6,919,341; 6,919,348; 6,919,392; 6,923,968; 6,962,151; 6,974,893; 7,270,968; 7,305,986; 7,320,968; 7,338,968; 7,348,319; 7,354,416; 7,358,393; 7,358,402; 7,361,650; 7,364,752; 7,371,408; 7,371,409; 7,377,866; 7,378,418; 7,378,423; 7,384,354; 7,384,650; 7,392,398; 7,392,844; 7,396,341; 7,396,822; 7,416,752; 7,422,388; 7,423,391; 7,425,326; 7,425,333; 7,494,815; 7,520,866; 7,731,986; 7,772,462; 7,893,287; 7,919,322; 7,964,183; 7,964,219; 7,964,357; 7,964,359; 7,964,402; 7,964,647; 7,968,263; 7,968,302; 7,968,351; 7,968,735; 8,008,006; 8,236,975; 8,277,822; 8,323,677; 8,327,844; 8,329,419; 8,329,752; 8,333,974; 8,334,413; 8,338,376; 8,338,385; 8,338,395; 8,338,408; 8,349,321; 8,354,409; 8,357,369; 8,357,375; 8,357,394; 8,357,677; 8,367,402; 8,367,415; 8,372,396; 8,372,968; 8,377,919; 8,383,359; 8,383,417; 8,387,351; 8,388,954; 8,394,367; 8,394,372; 8,394,377; 8,394,387; 8,394,405; 8,394,406; 8,394,407; 8,399,396; 8,415,337; 8,415,345; 8,415,348; 8,415,355; 8,415,363; 8,415,382; 8,415,393; 8,415,396; 8,420,650; 8,425,353; 8,591,983; 8,613,965; 8,647,639; 8,752,419; 8,822,407; 8,822,423; 8,926,493; 8,962,593; 8,962,630; 8,962,804; 8,975,382; 8,980,885; 9,227,983; 9,265,893; 9,271,866; 9,271,968; 9,285,364; 9,285,372; 9,326,974; 9,334,320; 9,345,677; 9,351,975; 9,353,366; 9,353,368; 9,353,371; 9,358,338; 9,359,367; 9,363,752; 9,371,377; 9,371,392; 9,371,393; 9,375,412; 9,375,494; 9,376,366; 9,381,305; 9,381,416; 9,382,321; 9,383,349; 9,383,370; 9,386,990; 9,387,360; 9,387,383; 9,388,425; 9,393,305; 9,393,351; 9,393,372; 9,394,344; 9,395,364; 9,402,919; 9,408,393; 9,408,893; 9,410,954; 9,416,366; 9,416,367; 9,416,371; 9,421,351; 9,422,335; 9,630,930; 9,650,393; 9,650,395; 9,650,416; 9,708,397; 9,822,351; 9,879,267; 9,974,302; 9,974,839; 9,975,919; 9,983,185
Attorneys Christopher Don Mays; Edward G. Poplawski; James R. Hannah; Lisa Kobialka; Olivia M Kim; Paul J. Andre; Ryan R. Smith
Firms Kramer Levin Naftalis & Frankel LLP; Wilson Sonsini Goodrich & Rosati; Wilson Sonsini Goodrich & Rosati, P.C.; Wilson Sonsini Goodrich and Rosati
Link to Docket External link to docket
Biologic Drugs cited in Finjan, Inc. v. Qualys Inc.

The biologic drugs covered by the patents cited in this case are ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , and ⤷  Try it Free .

Details for Finjan, Inc. v. Qualys Inc. (N.D. Cal. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-03-14 50 Opposition/Response to Motion ,975,305 (“’305 Patent”) to allege that Finjan should be precluded 8 from asserting different claims…on Finjan’s patent license to Trend Micro (the “Agreement”). 7 Under the Agreement, 8 9 10 11…motion for leave to assert patent exhaustion and implied 7 license defenses. 8 2. …Martin Corp. v. Network Sols., Inc., 194 F.3d 980 (9th Cir. 1999) .................................…Martin Corp. v. Network 15 Sols., Inc., 194 F.3d 980, 986 (9th Cir. 1999). 16 Qualys alleges External link to document
2020-03-16 52 Response ( Non Motion ) , 944 9 F.3d at 907; Poly-America, 839 F.3d at 1136. 10 Dkt. 42-5 ‘968 patent at Figure… 907; Poly-America, 839 F.3d at 18 1136. Judge Alsup also noted that the Patent Office similarly interpreted… ’154 patent (1-2, 6-7) 9 Transmitter ’968 patent (6) 10 …. 42-2 ’494 patent at 22:9; Dkt. 42-4 ’154 patent at 17:48-49, 18:17-18, 18:26-27; 3 Rubin Decl. ¶…53; Rubin Decl. at ¶ 49. 9 ’494 Patent. Claim 10 of the ’494 Patent states that the receiver External link to document
2020-04-13 60 Exhibit F 90071 Telephone: (323) 210-2901 6 Facsimile: (866) 974-7329 7 RYAN R. SMITH (SBN 229323… a processor that ‘154 Patent: Abstract; Claims 1, 6; Figs. 1-5; 2:64-67; 3:1-67; 4:15-26… 6 QUALYS’S PATENT L.R. 4-2 DISCLOSURES … ’408 Patent: Abstract; Claims 1, 8, 9, 22; Figs. 1, 2, 5, 6, 7; 1:59-2:65; 3:22-45;… ’154 Patent: Figs. 2-5; 6:60-65, 8:54-60, 15:26-29; claims 1-3 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
AstraZeneca
McKinsey
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.